Claims
- 1. A process for preparing a polyurethane film comprising:electrodepositing the film onto a substrate from a polyurethane dispersion; and removing the film from the substrate.
- 2. The process of claim 1 wherein the electrodepositing further comprisesapplying a voltage of at least 0.5V to the substrate, relative to a Ag/AgCl reference electrode; and allowing the polyurethane dispersion to deposit onto the substrate.
- 3. The process of claim 1, wherein the dispersion is formed in a two or more step process wherein,(1) in a first step a nonionic prepolymer is formed and, in a subsequent step, (2) an aqueous dispersion of the prepolymer is formed, in the presence of an anionic surfactant, both steps occurring in the substantial absence of an organic solvent.
- 4. The process of claim 3 wherein the prepolymer is prepared from a polyurethane prepolymer formulation including a diisocyanate and an active hydrogen containing material.
- 5. The process of claim 4 wherein the diisocyanate is either:(a) an aliphatic diisocyanate; or (b) an aromatic diisocyanate selected from the group consisting of MDI, TDI, and mixtures thereof; and wherein the active hydrogen containing material is either:(a) a mixture of a high molecular weight diol and a low molecular weight diol; or (b) a high molecular weight diol, wherein when the active hydrogen containing material does not include a low molecular weight diol, the prepolymer is dispersed in water which includes a difunctional amine chain extender.
- 6. The process according to claim 1 wherein the dispersion has a particle size of from 0.9 microns to 0.05 microns.
- 7. The process according to claim 1 wherein the dispersion has a solids content of from 5 to 60 weight percent.
- 8. A process for preparing a polyurethane film shaped for use in a medical application, said process comprising:(A) exposing a substrate having a shape suitable for making a film for a medical application to a polyurethane dispersion, said dispersion comprising a nonionic polyurethane prepolymer and an anionic surfactant and being substantially free of organic solvent; (B) electrodepositing said dispersion onto said substrate to form a film on said substrate; and (C) removing said film from said substrate to form a film shaped for said medical application.
- 9. The process of claim 8, wherein said polyurethane film shaped for use in a medical application is a glove, a condom, a medical bag, an angioplasty balloon, or a catheter.
- 10. The process of claim 8, wherein said polyurethane film shaped for use in a medical application is a glove and said substrate is glove shaped.
- 11. The process of claim 8, wherein said electrodepositing comprises:applying a voltage of at least 0.5V to the substrate, relative to a Ag/AgCl reference electrode; and allowing said polyurethane dispersion to deposit onto said substrate.
Parent Case Info
This application claims the benefit of U.S. Ser. No. 60/129,277 filed Apr. 14, 1999.
US Referenced Citations (43)
Foreign Referenced Citations (18)
Number |
Date |
Country |
197 08 451 |
Mar 1997 |
DE |
0 167 188 |
Jan 1986 |
EP |
0 279 198 |
Aug 1988 |
EP |
1 243 604 |
Aug 1971 |
GB |
1 432 112 |
Apr 1976 |
GB |
49047427 |
Nov 1975 |
JP |
55052359 |
Apr 1980 |
JP |
02204032 |
Aug 1990 |
JP |
05005094 |
Jan 1993 |
JP |
09165425 |
Jun 1997 |
JP |
10161397 |
Jun 1998 |
JP |
9508583 |
Mar 1995 |
WO |
9742247 |
Nov 1997 |
WO |
WO 9825747 |
Jun 1998 |
WO |
9831760 |
Jul 1998 |
WO |
WO 9841522 |
Sep 1998 |
WO |
9841554 |
Sep 1998 |
WO |
9923129 |
May 1999 |
WO |
Provisional Applications (1)
|
Number |
Date |
Country |
|
60/129277 |
Apr 1999 |
US |